Drugs / AZD9819
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01166698 | Aug 2010 → Jan 2011 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD9819 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01166698 ↗ |
| Route | Inhaled | “Inhaled single doses of suspension via SPIRA nebuliser” NCT01166698 ↗ |